by Maria Zannes | Jul 28, 2020 | Press Releases
JULY 28, 2020 (San Antonio, TX) bioAffinity Technologies, a privately-held biotech company, today announced it has closed a non-brokered, secured convertible note (“Note”) financing for proceeds of $5,000,000.00 (the “Offering”). The proceeds...
by Maria Zannes | Jul 23, 2020 | Events
Dr. Lydia Bederka will present the poster “Sputum-Derived Cellular Profiles Produced by Flow Cytometric Analysis” (Poster #P223) at the International Society for the Advancement of Cytometry conference, CYTO2020 on August 4-5, 2020. Cytometry is the quantitative...
by Maria Zannes | Jul 7, 2020 | Press Releases
OrbiMed Partner and Co-Founder of Alexion increases leadership role in oncology focused private company JULY 7, 2020 (San Antonio, TX) bioAffinity Technologies, a privately-held cancer diagnostics and therapeutics company, today announced that Stephen Squinto, Ph.D.,...
by Maria Zannes | Jun 16, 2020 | Press Releases
Philanthropist was Devoted to Bringing Life-Saving Tests and Treatments to Those In Need JUNE 16, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biomedical company, today named its research laboratories in memoriam of Harvey Sandler, a businessman...
by Maria Zannes | Jun 10, 2020 | Press Releases
Trial results of automated test demonstrate non-invasive CyPath® Lung is highly accurate in finding lung cancer FAQ: Answers to Questions about Cypath® Lung JUNE 10, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced its...
